19 February 2016 - The U.S. FDA yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm